Fractyl Health (GUTS) Cash from Financing Activities (2023 - 2026)

Fractyl Health (GUTS) has 4 years of Cash from Financing Activities data on file, last reported at $4.1 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 2300.58% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $108.9 million (up 27468.35% YoY) and the FY2025 annual result came in at $105.0 million, up 3.69% from the prior year.
• Cash from Financing Activities eased to $4.1 million in Q1 2026, from $25.2 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $101.0 million in Q1 2024 to a low of -$556000.0 in Q4 2023.
• A 4-year average of $18.3 million and a median of $171000.0 in 2025 frame the typical range for Cash from Financing Activities.
• The widest YoY moves for Cash from Financing Activities: up 5050200.0% in 2024, down 117.86% in 2024.
• Tracing GUTS's Cash from Financing Activities over 4 years: stood at -$556000.0 in 2023, then jumped by 112.05% to $67000.0 in 2024, then jumped by 37544.78% to $25.2 million in 2025, then sank by 83.72% to $4.1 million in 2026.
• The last three Cash from Financing Activities figures came in at $4.1 million (Q1 2026), $25.2 million (Q4 2025), and $78.1 million (Q3 2025), per Business Quant data.